InterCure Ltd. (TASE: INCR)
Health Care · Pharmaceuticals · IL
₪2.62
-6.89% today · -53.5% 1Y
InterCure Ltd. (TASE: INCR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $47.97M and employs 285 people.
Over the last twelve months the share price has lost 53.5%, trading between 2.25 and 5.70.
Tweenvest scores InterCure Ltd. across four factors: quality 55/100, value 69/100, growth 90/100. Its strongest factor is growth.
INCR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $47.97M
- Revenue (TTM)
- $84.76M
- P/E
- —
- EPS
- -0.66
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- ₪5.70
- 52-week low
- ₪2.25
- Avg volume (3M)
- —
- Shares outstanding
- 54.68M
- Employees
- 285
- Next earnings
- —
About InterCure Ltd.
InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to production, marketing, and distribution of medical cannabis products. The company's product line features dried cannabis flowers and an oil-based cannabis extract. Additionally, InterCure allocates investments to the biomedical sector. Established in 1994, the firm's main headquarters are situated in Herzliya, Israel.
- ISIN
- IL0011063760
- Founded
- 1994
- Listed since
- Sep 9, 2007
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.